Inhibition of morphogenetic cell interactions by 6-diazo-5-oxo-norleucine (DON).
D000241:Adenosine / Q000494:pharmacology; D000620:Aminoimidazole Carboxamide / Q000494:pharmacology; D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology*; D002450:Cell Communication; D002454:Cell Differentiation / Q000187:drug effects*; D003980:Diazooxonorleucine / Q000494:pharmacology*; D004627:Embryonic Induction / Q000187:drug effects*; D005944:Glucosamine / Q000494:pharmacology; D005973:Glutamine / Q000494:pharmacology; D006151:Guanosine / Q000494:pharmacology; D007684:Kidney Tubules / Q000196:embryology*; D051379:Mice; D009024:Morphogenesis; D009924:Organ Culture Techniques
D001391:Azo Compounds; D003980:Diazooxonorleucine; D005973:Glutamine; D006151:Guanosine; D000620:Aminoimidazole Carboxamide; D000241:Adenosine; D005944:Glucosamine